Product Information

TADALAFIL 20 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1887 per EA under NDC 29300028905. Its NADAC has been published 133 times since May 1, 2024.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 20 MG TABLET

tadalafil
$0.1887per EA

Strength

20 mg/1

NDC

29300028905

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA209250

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

3/26/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 20 MG TABLET has been published 133 times since May 1, 2024, and over the history we have for it it has declined 3.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1887 per EA
All-time high$0.2775 (Nov 13, 2024)
All-time low$0.1568 (Nov 20, 2024)
52-week high$0.2101
52-week low$0.1582
Median price$0.2017
Average price$0.2019
Largest weekly change-43.5% (Nov 20, 2024)
Weeks tracked133
Tracking sinceMay 1, 2024

Price History

1W

0.0%

1M

+12.9%

3M

+19.3%

6M

+5.1%

1Y

-10.8%

3Y

N/A

5Y

N/A

All

-3.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 20 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1887 per EA (NDC 29300028905), effective Nov 11, 2026.

How has the price of TADALAFIL 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 20 MG TABLET has declined 3.5%. It has been tracked across 133 weekly CMS publications since May 1, 2024.

What are the highest and lowest recorded NADAC prices for TADALAFIL 20 MG TABLET?

Since May 1, 2024, the NADAC for TADALAFIL 20 MG TABLET has ranged from a low of $0.1568 (Nov 20, 2024) to a high of $0.2775 (Nov 13, 2024), with a median of $0.2017 per EA.

Are there cheaper alternatives to TADALAFIL 20 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 20 MG TABLET, is $0.1448 per EA — about 23% below TADALAFIL 20 MG TABLET.

Who manufactures TADALAFIL 20 MG TABLET?

TADALAFIL 20 MG TABLET (NDC 29300028905) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.